FAQ   

 Symbol Lookup 
By using this website you hereby agree to and are bound by the Pink OTC Markets Inc. Terms of Service.










Home >>   Quotes & News >>   Quote >>   TTNP


To view quote, trade, company profile, news and filing information, please enable javascript on your browser.

Titan Pharmaceuticals, Inc. - TTNP

OTCQB / Security Type:

Contact Info

400 Oyster Point Blvd. Suite 505
South San Francisco CA United States

http://www.titanpharm.com

  • Phone: 650-244-4990
  • Fax:
  • E-mail: investors@titanpharm.com

Business Description

Officers and Directors

Marc Rubin President
Sunil Bhonsle President
Robert E. Farrell EVP

Service Providers

Auditor/Accountant

Legal Counsel

Investor Relation Firm

Other Information

Industry Classification 2836 - Biological products, except diagnostic
Jurisdiction of Incorporation DE ,USA
Year of Incorporation
CIK 0000910267
Non Exchange Listing
Market Cap 6.17851528E7
Shares Outstanding 58287880